Takeda Pharmaceutical Co Ltd

Arax Advisory Partners TAK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

7,178

Value ($000)

112

Weight

0.0%

2019 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	112	0.0%	7,178	12/31/2025
2025 Q3	11/14/2025	896	0.0%	61,174	9/30/2025
2025 Q2	8/12/2025	88	0.0%	773	6/30/2025
2025 Q1	5/15/2025	3	0.0%	234	3/31/2025
2024 Q3	11/6/2024	22	0.0%	1,556	9/30/2024
2024 Q2	8/6/2024	25	0.0%	1,914	6/30/2024
2024 Q1	5/14/2024	27	0.0%	1,956	3/31/2024
2023 Q4	2/6/2024	22	0.0%	1,536	12/31/2023
2023 Q3	11/14/2023	24	0.0%	1,532	9/30/2023
2023 Q2	8/14/2023	25	0.0%	1,564	6/30/2023
2023 Q1	5/16/2023	19	0.0%	1,152	3/31/2023
2022 Q1	5/12/2022	3	0.0%	201	3/31/2022
2021 Q4	2/8/2022	1	0.0%	101	12/31/2021
2021 Q2	8/2/2021	40	0.0%	2,372	6/30/2021
2020 Q4	2/3/2021	40	0.0%	2,200	12/31/2020
2020 Q3	11/12/2020	39	0.0%	2,200	9/30/2020
2020 Q2	8/6/2020	39	0.0%	2,200	6/30/2020
2020 Q1	5/13/2020	33	0.0%	2,200	3/31/2020
2019 Q4	2/7/2020	43	0.0%	2,200	12/31/2019